ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,784,708 | -15.8% | 765,833 | -4.6% | 0.64% | -6.9% |
| Q2 2023 | $24,688,730 | -23.3% | 803,167 | -10.1% | 0.69% | -22.9% |
| Q1 2023 | $32,181,363 | -21.0% | 893,192 | -13.4% | 0.90% | -18.1% |
| Q4 2022 | $40,754,574 | -5.5% | 1,031,269 | -4.0% | 1.10% | -14.6% |
| Q3 2022 | $43,143,000 | -47.8% | 1,073,745 | -45.4% | 1.28% | -6.8% |
| Q2 2022 | $82,623,000 | +2.1% | 1,965,336 | -5.4% | 1.38% | +25.6% |
| Q1 2022 | $80,908,000 | -9.5% | 2,076,728 | -7.4% | 1.10% | -0.8% |
| Q4 2021 | $89,357,000 | – | 2,242,330 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |